Literature DB >> 2757194

A highly sensitive, mixed-phase assay for chloramphenicol acetyltransferase activity in transfected cells.

D A Nielsen1, T C Chang, D J Shapiro.   

Abstract

We describe a simple, rapid yet extremely sensitive assay for chloramphenicol acetyltransferase (CAT) activity in extracts from transfected eukaryotic cells. Using our modified reaction conditions and the mixed-phase assay, less than 0.000010 unit of CAT activity in transfected cells can be reliably detected. The mixed-phase assay is based on the inability of the polar [3H]-acetyl-Coenzyme A (CoA) substrate to partition out of a urea containing aqueous phase into the nonpolar scintillation fluor, while the [3H]chloramphenicol reaction products partition into the toluene scintillation fluor and are quantitated by scintillation counting. The increased sensitivity of this assay is due to the optimization of the acetyl-CoA concentration, to a urea-containing aqueous phase which lowers the assay background, and to the use of extract blanks. The mixed-phase assay is simpler, is quantitative, uses less costly substrates, and is far more sensitive than the most widely used CAT assays, which require solvent extraction followed by thin-layer chromatography to separate the unreacted substrate from product.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757194     DOI: 10.1016/0003-2697(89)90193-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  20 in total

1.  Structure and expression of the human p68 RNA helicase gene.

Authors:  O G Rössler; P Hloch; N Schütz; T Weitzenegger; H Stahl
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

2.  cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Authors:  M Kitzmann; M Vandromme; V Schaeffer; G Carnac; J C Labbé; N Lamb; A Fernandez
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA.

Authors:  J Attal; M C Theron; C Puissant; L M Houdebine
Journal:  Gene Expr       Date:  1999

4.  Functional characterization of the promoter of pp63, a gene encoding a natural inhibitor of the insulin receptor tyrosine kinase.

Authors:  L Falquerho; L Paquereau; M J Vilarem; S Galas; G Patey; A Le Cam
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

5.  Regulatory functions of a non-ligand-binding thyroid hormone receptor isoform.

Authors:  T Hermann; X K Zhang; M Tzukerman; K N Wills; G Graupner; M Pfahl
Journal:  Cell Regul       Date:  1991-07

6.  Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome.

Authors:  H Klocker; F Kaspar; J Eberle; S Uberreiter; C Radmayr; G Bartsch
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

7.  An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2).

Authors:  G H Swift; Y Liu; S D Rose; L J Bischof; S Steelman; A M Buchberg; C V Wright; R J MacDonald
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma.

Authors:  D Strehlow; A Jelaska; K Strehlow; J H Korn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

9.  Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function.

Authors:  N Meller; Y C Liu; T L Collins; N Bonnefoy-Bérard; G Baier; N Isakov; A Altman
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

Authors:  D J Volsky; M Simm; M Shahabuddin; G Li; W Chao; M J Potash
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.